Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless
NCT ID: NCT04529798
Last Updated: 2024-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2016-11-22
2025-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SMR Stemless Shoulder Arthroplasty Clinical Study
NCT02679352
SMR Stemless Reverse Vs SMR Reverse Shoulder System
NCT04697004
S-33 SMR Shoulder HP Reverse Glenosphere
NCT05339815
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
NCT03726554
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder Bipolar System
NCT05358574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The follow up time-points are (as of standard of care and not different for this study):
* Baseline
* 6 weeks postop
* 6 months postop
* 12 months postop
* 24 months postop
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* approving written informed consent
Exclusion Criteria
* All adult patients with any of the SMR Stemless contraindication for use for the reverse configuration as reported in the current local Instruction for use.
* not consenting in participating in this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arthro Medics AG
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med Claudio Rosso
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudio Rosso, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Arthro Medics AG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arthro Medics AG
Basel, Canton of Basel-City, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.